|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, UT, USA
* To whom correspondence should be addressed. E-mail: donald.kohan{at}hsc.utah.edu.
Endothelin-1 (ET-1) inhibition of vasopressin (AVP)-stimulated cAMP accumulation in the collecting duct has been hypothesized to be mediated, at least in part, by nitric oxide (NO). To examine this, the effect of ET-1 on NO production by acutely isolated rat inner medullary collecting duct (IMCD) cell suspensions, and its role in mediating ET-1 effects on AVP-stimulated cAMP accumulation, were studied. ET-1 dose-dependently (first evident at 100 pM ET-1) increased IMCD NO production as determined by DAF-FM fluorescence. ETB receptor (BQ788), but not ETA receptor (BQ123), antagonism blocked this effect. Non-specific NOS inhibitors (L-NAME or L-NMMA) or NOS-1 inhibitors (SMTC or VNIO) inhibited the ET-1 response, while NOS-2 or NOS-3 inhibitors (L-NAA or 1400W) were ineffective. ET-1 also increased cGMP accumulation. ET-1 caused a 35% reduction in AVP-stimulated cAMP levels, however this response was not affected by L-NAME or SMTC. Addition of L-arginine, NADPH, tetrahydrobiopterin, or tempol (to reduce superoxide-dependent conversion of NO to peroxynitrate) did not affect the response. NO donors (SNAP or spermine NONOate), at concentrations that stimulated DAF-FM fluorescence and increased cGMP levels, did not alter AVP-stimulated cAMP accumulation in the IMCD cell suspensions. In conclusion, ET-1 stimulates IMCD NO production through activation of the ETB receptor and NOS-1. However, neither ET-1-mediated NO production nor NO donors inhibit AVP-stimulated cAMP accumulation, indicating that NO does not mediate ET-1 inhibition of cAMP in the IMCD.
This article has been cited by other articles:
![]() |
D. L. Kellogg Jr., J. L. Zhao, and Y. Wu Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans J Appl Physiol, November 1, 2009; 107(5): 1438 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Stow, M. L. Gumz, I. J. Lynch, M. M. Greenlee, A. Rudin, B. D. Cain, and C. S. Wingo Aldosterone Modulates Steroid Receptor Binding to the Endothelin-1 Gene (edn1) J. Biol. Chem., October 30, 2009; 284(44): 30087 - 30096. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nakano and D. M. Pollock Contribution of Endothelin A Receptors in Endothelin 1-Dependent Natriuresis in Female Rats Hypertension, February 1, 2009; 53(2): 324 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, A. Bagnall, P. K. Stricklett, D. Webb, Y. Kotelevtsev, and D. E. Kohan Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1635 - F1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Kellogg Jr., J. L. Zhao, and Y. Wu Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H123 - H129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nakano, J. S. Pollock, and D. M. Pollock Renal medullary ETB receptors produce diuresis and natriuresis via NOS1 Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1205 - F1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Fenton and M. A. Knepper Mouse Models and the Urinary Concentrating Mechanism in the New Millennium Physiol Rev, October 1, 2007; 87(4): 1083 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, A. Bagnall, P. K. Stricklett, K. Strait, D. J. Webb, Y. Kotelevtsev, and D. E. Kohan Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1274 - F1280. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |